Since the absolute clinical benefit of adjuvant chemotherapy in node negative breast cancer is modest estimated absolute benefit of 4 92 with vs 88 without in terms of 10 year distant recurrence in the NSABP B 20 trial, but the toxicity is significant, the selection of patients for adjuvant chemotherapy remains an important clinical issue 39 <a href=http://cialis.lat/discover-the-best-prices-for-cialis>cialis generic cost</a> This combination significantly improved disease free survival DFS compared to exemestane alone 34
0
